Long-Term Safety of Risankizumab in Patients with Psoriatic Disease: A Comprehensive Analysis from Clinical Trials

Long-Term Safety of Risankizumab in Patients with Psoriatic Disease: A Comprehensive Analysis from Clinical Trials

Abstract Introduction Risankizumab has demonstrated a favourable safety profile in patients with psoriatic disease (moderate-to-severe psoriasis [PsO] and psoriatic arthritis [PsA]). We evaluated the long-term safety of risankizumab in psoriatic disease. Methods Long-term safety was evaluated by ana...

Full description

Saved in:
Bibliographic Details
Main Authors: Kenneth B. Gordon (Author), Andrew Blauvelt (Author), Hervé Bachelez (Author), Laura C. Coates (Author), Filip E. Van den Bosch (Author), Blair Kaplan (Author), Willem Koetse (Author), Doug G. Ashley (Author), Ralph Lippe (Author), Ranjeeta Sinvhal (Author), Kim A. Papp (Author)
Format: Book
Published: Adis, Springer Healthcare, 2024-08-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items